Source link : https://www.newshealth.biz/health-news/new-monthly-paliperidone-palmitate-injectable-okd-for-schizophrenia/
The FDA approved a new monthly paliperidone palmitate (Erzofri) extended-release injectable suspension for treating schizophrenia in adults, Luye Pharma announced. An atypical antipsychotic, paliperidone palmitate is also indicated for schizoaffective disorder in adults, as a monotherapy or adjunct to mood stabilizers or antidepressants. Injections must be administered by a healthcare provider. “Using long-acting injectable (LAI) […]
Author : News Health
Publish date : 2024-07-29 18:55:32
Copyright for syndicated content belongs to the linked Source.
Categories